INKORZA
Live / Applied — Opposition pending (as of 24 Sept 2026)
What this means for you
Not registered yet, but its 12 Dec 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers. An opposition to it is pending before the Trademark Trial and Appeal Board, so it will register only if the opposition fails or is withdrawn.
Record
- Serial number
- 99544407
- Mark type
- Word mark
- Filed
- 12 Dec 2025
- Published for opposition
- 31 Mar 2026
- Attorney of record
- MARYAM ARASTU
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions
Owner
- AbbVie Inc., North Chicago, IL, US
- AbbVie Inc., North Chicago, IL, US
Board proceedings on this mark
- Opposition No. 91310636 — Corza Medical Inc. v. AbbVie Inc., filed 24 Sept 2026 (Pending)
- Extension of Time to Oppose No. 99544407 — Corza Medical Inc. v. AbbVie Inc., filed 27 Apr 2026 (Terminated)
Prosecution history
- 27 Sept 2026 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 24 Sept 2026 — OPPOSITION INSTITUTED NO. 999999
- 27 Apr 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 31 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Mar 2026 — PUBLISHED FOR OPPOSITION
- 25 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Mar 2026 — ASSIGNED TO EXAMINER
- 12 Dec 2025 — APPLICATION FILING RECEIPT MAILED
- 12 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 12 Dec 2025 — NEW APPLICATION ENTERED